Chimerix Profit Margin 2011-2019 | CMRX

Current and historical gross margin, operating margin and net profit margin for Chimerix (CMRX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Chimerix net profit margin as of September 30, 2019 is -1162.96%.
Chimerix Annual Profit Margins
Chimerix Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.116B $0.007B
Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.160B 27.39
Medtronic (MDT) Ireland $149.747B 20.69
Stryker (SYK) United States $74.065B 24.90
Boston Scientific (BSX) United States $61.077B 28.83
Baxter (BAX) United States $42.381B 25.70
Essilor Luxottica (ESLOY) France $33.712B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.238B 18.97
Terumo (TRUMY) Japan $26.963B 33.65
Lonza Group Ag (LZAGY) Switzerland $25.222B 0.00
Coloplast (CLPBY) Denmark $24.840B 38.33
ResMed (RMD) United States $21.637B 39.92
Smith & Nephew SNATS (SNN) United Kingdom $19.607B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $11.140B 529.97
Bio-Rad Laboratories (BIO) United States $10.533B 50.56
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Perrigo (PRGO) Ireland $7.324B 13.66
Hill-Rom Holdings (HRC) United States $7.238B 21.34
Canopy Growth (CGC) Canada $7.058B 0.00
Haemonetics (HAE) United States $5.958B 40.26
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.840B 30.24
ICU Medical (ICUI) United States $3.692B 24.07
Neogen (NEOG) United States $3.546B 59.33
GW Pharmaceuticals (GWPH) United Kingdom $3.178B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.061B 0.00
Quidel (QDEL) United States $2.984B 28.32
Aurora Cannabis (ACB) Canada $2.669B 0.00
Agios Pharmaceuticals (AGIO) United States $2.596B 0.00
National Vision Holdings (EYE) United States $2.423B 54.70
Cardiovascular Systems (CSII) United States $1.542B 0.00
InMode (INMD) Israel $1.364B 0.00
Aphria (APHA) $1.230B 0.00
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.182B 23.68
Phibro Animal Health (PAHC) United States $0.986B 18.46
NanoString Technologies (NSTG) United States $0.908B 0.00
TG Therapeutics (TGTX) United States $0.890B 0.00
Lantheus Holdings (LNTH) United States $0.803B 20.07
Eagle Pharmaceuticals (EGRX) United States $0.803B 30.76
Quanterix (QTRX) United States $0.704B 0.00
LeMaitre Vascular (LMAT) United States $0.697B 39.17
PetIQ (PETQ) United States $0.695B 16.97
Omeros (OMER) United States $0.662B 0.00
HEXO (HEXO) $0.563B 0.00
Cerus (CERS) United States $0.540B 0.00
Surmodics (SRDX) United States $0.532B 55.32
OraSure Technologies (OSUR) United States $0.485B 29.07
MacroGenics (MGNX) United States $0.474B 0.00
Owens & Minor (OMI) United States $0.445B 16.47
Organigram Holdings (OGI) Canada $0.400B 0.00
Meridian Bioscience (VIVO) United States $0.395B 13.57
Utah Medical Products (UTMD) United States $0.388B 28.08
BioLife Solutions (BLFS) United States $0.309B 125.75
Zynex (ZYXI) United States $0.293B 33.19
Bovie Medical (APYX) United States $0.273B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.265B 0.00
United Health Products (UEEC) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.244B 25.76
Vapotherm (VAPO) United States $0.244B 0.00
Repro-Med Systems (KRMD) United States $0.239B 0.00
Liberty Health Sciences (LHSIF) Canada $0.179B 0.00
InfuSystems Holdings (INFU) United States $0.164B 824.00
Green Organic Dutchman Holdings (TGODF) Canada $0.160B 0.00
Female Health (VERU) United States $0.159B 0.00
Rockwell Medical (RMTI) United States $0.147B 0.00
MTech Acquisition (KERN) United States $0.132B 0.00
Cytosorbents (CTSO) United States $0.129B 0.00
Fonar (FONR) United States $0.127B 8.98
United-Guardian (UG) United States $0.091B 22.91
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Chembio Diagnostics (CEMI) United States $0.076B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.063B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00